Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Shawn Patrick Griffin

Photo of Shawn Patrick Griffin
Title(s)Associate Health Sciences Professor, Clinical Pharmacy Practice
SchoolSchool of Pharmacy and Pharmaceutical Sciences
Address101 Theory, Suite 100
Irvine CA 92697-3958
Phone(949) 824-8009
ORCID ORCID Icon0000-0002-3818-2490 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Boston CollegeBSBiology
    University of North Carolina at Chapel HillPharmD
    UF Health Shands HospitalPGY1 Pharmacy Residency
    UF Health Shands HospitalPGY2 Oncology Pharmacy Residency

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Oncology pharmacist survey: Understanding task value and professional satisfaction. J Oncol Pharm Pract. 2026 Feb 13; 10781552261421501. Benitez LL, Signorelli J, Adler K, Cimino S, Darling J, Dotson E, Goodner JA, Harris C, McDevitt RL, Rasor B, Schroader BK, Sirek M, Vogel V, Wolff AS, Griffin SP. PMID: 41686733.
      View in: PubMed   Mentions:    Fields:    
    2. Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active Transformation. EJHaem. 2026 Feb; 7(1):e70221. Lee BJ, Griffin SP, Jeyakumar D, Gamayo A, Rezk SA, Naqvi K. PMID: 41613949; PMCID: PMC12849753.
      View in: PubMed   Mentions:
    3. Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia. Br J Haematol. 2026 Feb; 208(2):570-578. Lee BJ, Griffin SP, Doh J, Quach A, Sun Y, Chumnumsiriwath P, Ciurea SO, Ramos-Perez J, Bellman P, Jeyakumar D, Kongtim P, Naqvi K. PMID: 41224356; PMCID: PMC12916188.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma. Leuk Lymphoma. 2025 Dec; 66(13):2548-2552. Chumnumsiriwath P, Vittayawacharin P, Pinter-Brown L, Brem EA, Griffin SP, Kongtim P, Ciurea SO. PMID: 40840891; PMCID: PMC12767447.
      View in: PubMed   Mentions:    Fields:    
    5. R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2025 Dec; 25(12):e1014-e1021. Lee BJ, Griffin SP, Doh J, Quach A, Sun Y, Brem EA, Van Etten RA, Nelson EL, Coombs CC, Chan A. PMID: 40681431.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Comparison of standard versus adjusted dose of enoxaparin for venous thromboembolism prophylaxis in patients with obesity and cancer. J Oncol Pharm Pract. 2025 May 21; 10781552251345413. Angerman C, Ahn J, Gee-Rodriguez K, Conkey B, Tran C, Nguyen L, Guglielmo J, Roberts AJ, Lo M, Lee A, Saunders I, Willeford A, Lee D, Kim K, Cadiz C, Griffin SP, Pon T. PMID: 40398487.
      View in: PubMed   Mentions:    Fields:    
    7. Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT). Bone Marrow Transplant. 2025 Jul; 60(7):1065-1069. Chumnumsiriwath P, Vittayawacharin P, Ramos-Perez J, Jeyakumar D, Lee BJ, Doh J, Griffin S, Nguyen M, Hanna RM, Tran MH, Kongtim P, Ciurea SO. PMID: 40263635; PMCID: PMC12577200.
      View in: PubMed   Mentions: 2     Fields:    
    8. Time to complete oncology pharmacist tasks: A joint opinion of the Hematology/Oncology Pharmacy Association and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network. J Oncol Pharm Pract. 2025 Apr 01; 10781552251330252. Griffin SP, Signorelli J, Raheem F, Adler K, Benitez LL, Cheng RM, Dotson E, Fares M, Ganti BR, Hickey Zacholski E, Lasko AR, Lewallen AB, Lynch AC, Paulic N, Quach D, Vogel V, Yacobucci M, Riebandt G. PMID: 40170460.
      View in: PubMed   Mentions:    Fields:    
    9. Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation. Am J Hematol. 2025 Mar; 100(3):383-392. Kongtim P, Chumnumsiriwath P, Vittayawacharin P, Jeyakumar D, Lee BJ, Doh J, Griffin SP, Van Etten RA, Ciurea S. PMID: 39777927; PMCID: PMC12483468.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation. Haematologica. 2024 Nov 01; 109(11):3806-3810. Vittayawacharin P, Lee BJ, Griffin S, Doh J, Smith J, Nam H, Blodget E, Jeyakumar D, Kongtim P, Ciurea SO. PMID: 38988270; PMCID: PMC11532715.
      View in: PubMed   Mentions: 1     Fields:    
    11. Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience. Ann Hematol. 2024 Dec; 103(12):5395-5403. Lee BJ, Griffin SP, Doh J, Ciurea SO, Jeyakumar D, Kongtim P, Naqvi K. PMID: 39438320; PMCID: PMC11695490.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies. Cancer Med. 2024 Oct; 13(19):e70310. Lee BJ, Liu J, Griffin SP, Doh J, Ciurea SO, Kongtim P, Brem EA. PMID: 39394843; PMCID: PMC11470199.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center. JCO Oncol Pract. 2024 Dec; 20(12):1596-1603. Wooten A, Wright J, Thakrar T, Barron A, Grove M, Duggal R, Lee BJ, Doh J, Di Tomasso PM, Joe MD, Griffin SP. PMID: 38941576.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection. Transplant Cell Ther. 2024 08; 30(8):816.e1-816.e10. Lee BJ, Vittayawacharin P, Griffin SP, Doh J, Nam HH, Jeyakumar D, Blodget E, Kongtim P, Ciurea SO. PMID: 38710303; PMCID: PMC12577209.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Eculizumab for Shiga-toxin-induced hemolytic uremic syndrome in adults with neurological involvement. EJHaem. 2024 Jun; 5(3):548-553. Lee BJ, Arter Z, Doh J, Griffin SP, Vittayawacharin P, Atallah S, Shieh KR, Tran MH, Jodele S, Kongtim P, Ciurea SO. PMID: 38895057; PMCID: PMC11182416.
      View in: PubMed   Mentions: 1  
    16. Treatment-related toxicity disparities in adult Hispanic acute lymphoblastic leukemia patients receiving pegaspargase-based regimens: A multicenter electronic health research network study. Hematol Oncol. 2024 Mar; 42(2):e3254. Lee BJ, Griffin SP. PMID: 40970446.
      View in: PubMed   Mentions:    Fields:    
    17. HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia. Eur J Haematol. 2024 Mar; 112(3):392-401. Lee BJ, Griffin SP, Doh J, Chan A, Ciurea SO, Jeyakumar D, Fleischman AG, Naqvi K, Pannunzio NR, O'Brien S, Kongtim P. PMID: 37933194; PMCID: PMC12577190.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series. Acta Haematol. 2023 Oct 09; 1-7. Griffin SP, Lee B, Doh J, Paradyse AR, Jeyakumar D, Arter Z, Nam H, Blodget E, Smith J, Valek A, Vittayawacharin P, Kongtim P, Ciurea SO. PMID: 38059378.
      View in: PubMed   Mentions:    Fields:    
    19. Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey. J Oncol Pharm Pract. 2024 Mar; 30(2):332-341. Griffin SP, Signorelli JR, Lasko A, Andrick BJ, Doan D, Hough S, Riebandt G, Harnicar S. PMID: 37194276; PMCID: PMC10943602.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change. Eur J Haematol. 2023 Jul; 111(1):154-160. Lee BJ, Kongtim P, Doh J, Griffin SP, Chan A, O'Brien S, Ciurea SO, Jeyakumar D. PMID: 37086155.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    21. Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2023 06; 29(6):397.e1-397.e6. Vittayawacharin P, E'Leimat G, Lee BJ, Griffin S, Doh J, Nam H, Blodget E, Jeyakumar D, Kongtim P, Ciurea SO. PMID: 36878429.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    22. Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia. Am J Hematol. 2023 05; 98(5):E113-E115. Lee BJ, Griffin SP, Doh J, Kongtim P, Chan A, O'Brien S, Jeyakumar D, Ciurea SO. PMID: 36794446.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch. Am J Hematol. 2022 12; 97(12):E439-E443. Lee BJ, Griffin SP, Doh J, Chan A, O'Brien S, Jeyakumar D, Ciurea SO, Becker PS, Kongtim P. PMID: 36057135.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome. Bone Marrow Transplant. 2021 01; 56(1):121-128. Agrawal V, Ranganath P, Ervin KD, Schmidt CA, Cox EA, Nelson RP, Schwartz JE, Zaid MA, Abonour R, Robertson MJ, Brinda BJ, Griffin SP, Thakrar TC, Farag SS. PMID: 32623447.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2019 02; 54(2):218-225. Griffin SP, Wheeler SE, Wiggins LE, Murthy HS, Hsu JW, Richards AI. PMID: 29884851.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients. Prog Transplant. 2016 Dec; 26(4):314-321. Griffin SP, Nelson JE. PMID: 27628498.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Shawn's Networks
    Concepts (88)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (22)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California